SFRP1 and pulmonary fibrosis: While the latter studies were mainly focused on SSc dermal fibroblasts, our group confirmed the reduced expression of SFRP1 and DKK1, coupled with Wnt overexpression, in SSc lung fibroblasts, supporting the protective role of these Wnt antagonists also in SSc lung fibrosis [14].